Skip to content

Pipeline TM Flex Embolization Device with Shield Technology TM PED2-500-30Recalls & reported problems

Micro Therapeutics, Inc. · STENT PED2-500-30 V08 MDR · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00763000449582), received between Nov 21, 2025 and Sep 9, 2026 — classified as 5 malfunctions.

The most frequently reported specific device problem is “Activation Failure” (5 reports).

12 other recalls cover devices cleared under the same FDA submission (P100018); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation Failure5
  • Material Deformation2
  • Physical Resistance/Sticking1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4
  • Vascular Dissection1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 9, 2026Activation Failure

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50690516 ↗
  • MalfunctionAug 26, 2026Material Deformation; Activation Failure

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50457076 ↗
  • MalfunctionMar 25, 2026Activation Failure; Physical Resistance/Sticking

    ADDITIONAL INFORMATION WAS RECEIVED. NO CAUSES OR CONTRIBUTING FACTORS FOR THE EVENT WERE IDENTIFIED. RESISTANCE WAS NOTED IN THE DISTAL SECTION OF THE CATHETER. THE CATHETER WAS FLUSHED PER IFU DURING THE PROCEDURE. THE PIPELINE WAS NOT PLACED IN A VESSEL BEND WHEN IT FAILED TO OPEN, AND NO ADDITIONAL STEPS OR OTHER DEVICES (SUCH AS RESHEATHING, WIRE OR CATHETER MANIPULATION, OR BALLOON USE) WERE ATTEMPTED TO OPEN THE PIPELINE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24686762 ↗
  • MalfunctionJan 29, 2026Activation Failure

    MEDTRONIC RECEIVED INFORMATION REGARDING PIPELINE FLEX WITH SHIELD EMBOLIZATION DEVICE THAT FAILED TO OPEN. THE PATIENT WAS UNDERGOING A PROCEDURE FOR FLOW DIVERTER STENT TREATMENT OF AN INTERNAL CAROTID ARTERY (ICA) C4 SEGMENT UNRUPTURED AMORPHOUS ANEURYSM. THE ANEURYSM MAX DIAMETER WAS 10MM AND THE NECK DIAMETER WAS 5.3MM. THE DISTAL LANDING ZONE WAS 4.5MM; THE PROXIMAL LANDING ZONE WAS 4.9MM. VESSEL TORTUOSITY WAS MODERATE. IT WAS REPORTED THAT THE PIPELINE AND ALL ACCESSORY DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). AFTER THE CATHETER DELIVERY SYSTEM WAS POSITIONED IN LACE, THE PIPELINE WAS HYDRATED AND DELIVERED TO THE MIDDLE CEREBRAL ARTERY (MCA) STRAIGHT SEGMENT. THE MICROCATHETER WAS RETRACTED TO START DEPLOYMENT OF THE PIPELINE STENT. HOWEVER, THE TIP OF THE STENT DID NOT OPEN. DEPLOYMENT WAS CONTINUED WITH REPEATED PUSHING AND PULLING BUT THE TIP STILL DID NOT OPEN. THE PIPELINE WAS FULLY RESHEATHED IN THE MICROCATHETER AND REPOSITIONED AT THE PROXIMAL END OF THE POSTERIOR COMMUNICATING ARTERY (PCOM) FOR DEPLOYMENT BUT THE PIPELINE STILL DID NOT OPEN. THE DEVICE WAS REMOVED AND REPLACED TO COMPLETE THE PROCEDURE SUCCESSFULLY. THERE WAS NO HARM O

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24209703 ↗
  • MalfunctionNov 21, 2025Material Deformation; Activation Failure; Material Deformation; Activation Failure

    ADDITIONAL INFORMATION WAS RECEIVED. THE CAUSE OF THE PIPELINE FAILURE TO OPEN WAS NOT DETERMINED. THE PIPELINE HAD NOT BEEN PLACED IN A VESSEL BEND WHEN IT FAILED TO OPEN, AND IT WAS NOT RESHEATHED DURING THE PROCEDURE. NO VISIBLE DAMAGE WAS OBSERVED ON THE PHENOM 27 MICROCATHETER

    Patient problems: Vascular Dissection

    MAUDE report 23620836 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P100018. One submission often covers many models, so check the product and lot details in each record.

  • Z-1245-2025 · Jan 30, 2025 · Open, Classified
    Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-027-350-12, PED3-027-350-14, PED3-027-350-16, PED3-027-350-20, PED3-027-350-25, PED3-027-400-12, PE
  • Z-1246-2025 · Jan 30, 2025 · Open, Classified
    Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250-14, PED3-021-350-20, PED3-021-250-20, PED3-021-300-16, PED3-021-300-20, PE
  • Z-2402-2021 · Jul 13, 2021 · Open, Classified
    Pipeline Flex Embolization Device
  • Z-2403-2021 · Jul 13, 2021 · Open, Classified
    EV3 Pipeline Flex Embolization Device with Flex Shield Technology
  • Z-1527-2020 · Feb 14, 2020 · Terminated
    ev3 Pipeline Flex Embolization Device. For neurological endovascular use.
  • Z-0307-2017 · Oct 5, 2016 · Terminated
    Pipeline Embolization Device (Pipeline Classic) The device is indicated for the endovascular treatment of adults (22 year of age or older) with large or giant widenecked intracrani
  • Z-0308-2017 · Oct 5, 2016 · Terminated
    Alligator Retrieval Device The device is intended for use in the peripheral and neurovasculature for foreign body removal. Catalog No. FA-88810-20V04 FA-88810-20V06 FA-88810-30V04
  • Z-0309-2017 · Oct 5, 2016 · Terminated
    Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled
  • Z-0310-2017 · Oct 5, 2016 · Terminated
    X-Celerator Hydrophilic Exchange Guidewire Catalog No. 103-0601-300 103-0601-350V10 103-0602-350V06 103-0601-300V01 103-0602-300 103-0602-350V09 103-0601-300V02 103-0602-300V01 10
  • Z-0120-2016 · Sep 4, 2015 · Terminated
    -Pipeline Embolization Device -Pipeline Flex Embolization Device The Pipeline and Pipeline Flex Embolization Devices consist of a permanent implant combined with a guidewire based
  • Z-1453-2014 · Apr 1, 2014 · Terminated
    Pipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery.
  • Z-2045-2013 · Jul 19, 2013 · Terminated
    Pipeline Embolization Device (PED) The Pipeline Embolization Device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide-neck

Other Intracranial aneurysm flow diverter devices

All Intracranial aneurysm flow diverter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page